IDH1 and glioma: applied the CIBERSORTx platform to construct and validate a glioma cell signature matrix encompassing both neoplastic and non-neoplastic cell types derived from single-cell RNA-seq of IDH-wildtype and IDH-mutant patient gliomas (31).